CN(C)c1ccc(/C=c2/c3ccccc3n3c2cc(C24CC5CC(CC(C5)C2)C4)[n+]3C)cc1.O=S(=O)([O-])C(F)(F)F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?